Concussion Recovery and Support Program (CRISP) for Young Adults
This study is testing a new program called CRISP (Concussion Recovery and Support Program) for young adults aged 18-29 who have had a concussion (mild traumatic brain injury) and are still experiencing headaches. CRISP is a behavioral therapy that helps people understand and express their emotions, which may help with persistent symptoms like headaches. You could join if you were diagnosed with a concussion between two weeks and two years ago, and have new or worsening headaches. The study aims to see if CRISP is practical and acceptable, and to gather early information on whether it helps reduce concussion symptoms, especially headaches. The study plans to enroll 40 participants, but its current recruitment status is unclear.
- Study design
- This is a pilot randomized controlled trial, meaning participants will be randomly assigned to different groups. The study plans to enroll 40 individuals.
- What's involved
- You would complete 6 sessions of CRISP with a therapist over Zoom, each lasting 60 minutes. You would also fill out surveys at the beginning, at 5 weeks, and at 10 weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your progress will be measured at 10 weeks after starting the program.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Concussion Recovery and Support Program
At a glance
Conditions
Where it's being run
2 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Treatment Evaluation Inventory, short form10 weeks
Self-report form regarding acceptability of treatment approach. Minimum 0, maximum 24 (6 items x 4 likert), higher scores indicate higher rating of treatment acceptability.